AIxCrypto Holdings, Inc. (AIXC)
1.09
+0.05
(+4.81%)
USD |
NASDAQ |
Sep 18, 16:00
1.11
+0.02
(+1.83%)
After-Hours: 20:00
AIxCrypto Holdings Enterprise Value : 26.93M for Sept. 18, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 26.93M |
| September 17, 2026 | 25.92M |
| September 16, 2026 | 24.30M |
| September 15, 2026 | 25.61M |
| September 14, 2026 | 28.95M |
| September 11, 2026 | 23.01M |
| September 10, 2026 | 19.85M |
| September 09, 2026 | 19.15M |
| September 08, 2026 | 18.84M |
| September 04, 2026 | 19.23M |
| September 03, 2026 | 18.96M |
| September 02, 2026 | 20.47M |
| September 01, 2026 | 20.66M |
| August 31, 2026 | 21.33M |
| August 28, 2026 | 20.71M |
| August 27, 2026 | 21.93M |
| August 26, 2026 | 23.49M |
| August 25, 2026 | 23.72M |
| August 24, 2026 | 23.82M |
| August 21, 2026 | 27.54M |
| August 20, 2026 | 28.65M |
| August 19, 2026 | 36.24M |
| August 18, 2026 | 31.58M |
| August 17, 2026 | 19.24M |
| August 14, 2026 | 18.57M |
| Date | Value |
|---|---|
| August 13, 2026 | 18.85M |
| August 12, 2026 | 19.89M |
| August 11, 2026 | 21.01M |
| August 10, 2026 | 20.84M |
| August 07, 2026 | 21.51M |
| August 06, 2026 | 21.58M |
| August 05, 2026 | 20.48M |
| August 04, 2026 | 21.02M |
| August 03, 2026 | 20.81M |
| July 31, 2026 | 18.26M |
| July 30, 2026 | 18.43M |
| July 29, 2026 | 18.02M |
| July 28, 2026 | 21.54M |
| July 27, 2026 | 21.57M |
| July 24, 2026 | 21.49M |
| July 23, 2026 | 20.45M |
| July 22, 2026 | 21.04M |
| July 21, 2026 | 20.60M |
| July 20, 2026 | 18.87M |
| July 17, 2026 | 20.56M |
| July 16, 2026 | 22.68M |
| July 15, 2026 | 24.70M |
| July 14, 2026 | 24.91M |
| July 13, 2026 | 23.49M |
| July 10, 2026 | 25.51M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cibus, Inc. | 388.87M |
| Arrowhead Pharmaceuticals, Inc. | 9.157B |
| NovelStem International Corp. | 2.190M |
| Oncolytics Biotech, Inc. | 92.30M |
| Sangamo Therapeutics, Inc. | 51.77M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.188M |
| Total Expenses (Quarterly) | 4.188M |
| EPS Diluted (Quarterly) | -0.2064 |
| Earnings Yield | -865.3% |
| Normalized Earnings Yield | -836.92 |